Insights

Regional Expansion TheOTCLab has a strong focus on European markets with existing distribution partners and plans to launch products in multiple EU countries such as Italy, Portugal, Estonia, Latvia, Lithuania, and the US. This presents opportunities to engage regional distributors, negotiate co-marketing arrangements, and identify country-specific regulatory support needs.

OTC Self-Care Specializing in natural, easy-to-use OTC self-care products across multiple categories (wart treatment, antifungal, kids care, menopause support, nail bite prevention, ear care, feminine care), offering ample cross-sell potential to expand into related pharmacist-led OTC portfolios and retailer shelves.

CE Certified Trust ISO 13485 and recent EU CE mark certification for Dr. Yglo presence signals strong quality and regulatory credibility, enabling B2B partners to market into regulated channels with lower compliance risk and faster time-to-market.

Strategic Leadership A management team with extensive European brand-building experience and a track record across regulatory classes, presenting opportunities for channel partnerships, private-label discussions, and collaboration on regional branding programs to accelerate market entry.

Growth via Partnerships Growing distribution network and ongoing hires in key markets indicate a scale-up phase ideal for channel partners, distributors, and retailers seeking innovative OTC brands with international reach and potential for joint marketing and seasonal promotions.

TheOTCLab (B Corp™) Tech Stack

TheOTCLab (B Corp™) uses 8 technology products and services including WordPress, RSS, Microsoft Excel, and more. Explore TheOTCLab (B Corp™)'s tech stack below.

  • WordPress
    Content Management System
  • RSS
    Content Management System
  • Microsoft Excel
    Editors
  • JSON-LD
    Javascript Frameworks
  • WPBakery
    Page Builders
  • YouTube
    Video Players
  • HTTP/3
    Web & Portal Technology
  • WPML
    Web Platform Extensions

TheOTCLab (B Corp™)'s Email Address Formats

TheOTCLab (B Corp™) uses at least 1 format(s):
TheOTCLab (B Corp™) Email FormatsExamplePercentage
First.Last@theotclab.comJohn.Doe@theotclab.com
63%
First@theotclab.comJohn@theotclab.com
37%

Frequently Asked Questions

What is TheOTCLab (B Corp™)'s official website and social media links?

Minus sign iconPlus sign icon
TheOTCLab (B Corp™)'s official website is theotclab.com and has social profiles on LinkedIn.

What is TheOTCLab (B Corp™)'s NAICS code?

Minus sign iconPlus sign icon
TheOTCLab (B Corp™)'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does TheOTCLab (B Corp™) have currently?

Minus sign iconPlus sign icon
As of July 2026, TheOTCLab (B Corp™) has approximately 18 employees across 1 continents, including Europe. Key team members include Founder & Ceo: A. S.Founder: J. H.Business Development Manager: D. K.. Explore TheOTCLab (B Corp™)'s employee directory with LeadIQ.

What industry does TheOTCLab (B Corp™) belong to?

Minus sign iconPlus sign icon
TheOTCLab (B Corp™) operates in the Pharmaceutical Manufacturing industry.

What technology does TheOTCLab (B Corp™) use?

Minus sign iconPlus sign icon
TheOTCLab (B Corp™)'s tech stack includes WordPressRSSMicrosoft ExcelJSON-LDWPBakeryYouTubeHTTP/3WPML.

What is TheOTCLab (B Corp™)'s email format?

Minus sign iconPlus sign icon
TheOTCLab (B Corp™)'s email format typically follows the pattern of First.Last@theotclab.com. Find more TheOTCLab (B Corp™) email formats with LeadIQ.

When was TheOTCLab (B Corp™) founded?

Minus sign iconPlus sign icon
TheOTCLab (B Corp™) was founded in 2016.
TheOTCLab (B Corp™) logo

TheOTCLab (B Corp™)

Pharmaceutical ManufacturingNorth Holland, Netherlands11-50 Employees

TheOTCLab is a Netherlands-based pharmaceutical manufacturer and certified B-Corporation based in Amsterdam, North Holland, focused on everyday self-care through OTC consumer health products. The company emphasizes safety and quality, holding ISO 13485 certification, and seeks to expand access to natural, easy-to-use solutions worldwide. Its leadership team brings extensive experience in consumer health brands across Europe and regulatory fields.

The firm concentrates on the Dutch market, where it develops and markets its own self-care brands and also distributes third-party products, while building an international network of distribution partners. Its brand portfolio includes DR YGLO, FUNGEX, KIDSNER, MENORELAX, BITENER, EARCLIN, and NL-only offerings such as AUDISPRAY, VAGISIL, JUST FOR MEN, and BREATHE RIGHT. In August 2023, TheOTCLab received European Union CE marking for its Dr YGLO wart and verruca freezing device, enabling planned launches in several EU markets and the United States.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2016
Employees
11-50

Section iconFunding & Financials

  • $1M

    TheOTCLab (B Corp™)'s revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    TheOTCLab (B Corp™)'s revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.